{"id":4025,"date":"2017-10-22T02:19:21","date_gmt":"2017-10-22T02:19:21","guid":{"rendered":"http:\/\/blogs.sld.cu\/oserranob\/?p=4025"},"modified":"2017-10-23T19:00:19","modified_gmt":"2017-10-23T19:00:19","slug":"nuevas-variantes-mutaciones-y-asociaciones-de-riesgo","status":"publish","type":"post","link":"https:\/\/blogs.sld.cu\/oserranob\/2017\/10\/22\/nuevas-variantes-mutaciones-y-asociaciones-de-riesgo\/","title":{"rendered":"Nuevas variantes, mutaciones y asociaciones de riesgo"},"content":{"rendered":"<p>&#8211; <a title=\"Texto completo en ingl\u00e9s\" href=\"\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2657130\" target=\"_blank\">HSD3B1 and Response to a Nonsteroidal CYP17A1 Inhibitor in Castration-Resistant Prostate Cancer<\/a><br \/> &#8211; <a title=\"Texto completo en ingl\u00e9s\" href=\"\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2657131\" target=\"_blank\">Association of HSD3B1 Genotype With Response to Androgen-Deprivation Therapy for Biochemical Recurrence After Radiotherapy for Localized Prostate Cancer<\/a><br \/> &#8211; <a title=\"Nature Communications 2017;8:888. \" href=\"https:\/\/www.nature.com\/articles\/s41467-017-00895-9\" target=\"_blank\">Heterozygous RFX6 protein truncating variants are associated with MODY with reduced penetrance<\/a><br \/> &#8211; <a title=\"Molecular Psychiatry, 2017; DOI: 10.1038\/MP.2017.156. \" href=\"https:\/\/www.nature.com\/mp\/journal\/vaop\/ncurrent\/full\/mp2017156a.html\" target=\"_blank\">Dose-dependent expression of claudin-5 is a modifying factor in schizophrenia<\/a><br \/> &#8211; <a title=\"Nature Genetics, 2017; DOI: 10.1038\/ng.3970. \" href=\"https:\/\/www.nature.com\/ng\/journal\/vaop\/ncurrent\/full\/ng.3970.html\" target=\"_blank\">Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8211; HSD3B1 and Response to a Nonsteroidal CYP17A1 Inhibitor in Castration-Resistant Prostate Cancer &#8211; Association of HSD3B1 Genotype With Response to Androgen-Deprivation Therapy for Biochemical Recurrence After Radiotherapy for Localized Prostate Cancer &#8211; Heterozygous RFX6 protein truncating variants are associated with MODY with reduced penetrance &#8211; Dose-dependent expression of claudin-5 is a modifying factor in [&hellip;]<\/p>\n","protected":false},"author":125,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[11,13,15,29],"tags":[],"_links":{"self":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/4025"}],"collection":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/users\/125"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/comments?post=4025"}],"version-history":[{"count":2,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/4025\/revisions"}],"predecessor-version":[{"id":4064,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/4025\/revisions\/4064"}],"wp:attachment":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/media?parent=4025"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/categories?post=4025"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/tags?post=4025"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}